Information obtained from clinical studies has demonstrated that dysregulation or genetic variants in TGF-β-mediated signaling are associated with various reproductive disorders, including polycystic ovary syndrome, ovulation dysfunction and even ovarian cancers [52,53,54]. Here, TGFB1 is linked to polycystic ovary syndrome.